SCHEMBL209167

SCHEMBL209167

COC1CCC(N2CC[C@@H](Cc3c(Cl)cc(OCc4ccccc4)cc3Cl)C2=O)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 2/20 0.47
LMNA P02545 1/20 0.39
HRH3 Q9Y5N1 4/20 0.39
S1PR1 P21453 1/20 0.38
PRKX P51817 1/20 0.38
ACVR1 Q04771 1/20 0.38
S1PR5 Q9H228 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
KDM4C Q9H3R0 1/20 0.38
MCHR1 Q99705 1/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
CYP2D6 P10635 2/20 0.36
FDFT1 P37268 1/20 0.35
GRM5 P41594 1/20 0.35
GRM2 Q14416 1/20 0.35
HTR1A P08908 1/20 0.35
SLC6A4 P31645 1/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL209166 1.00 HSD11B1 (0.47) HSD11B1LMNAHRH3S1PR1PRKX
SCHEMBL209168 1.00 HSD11B1 (0.47) HSD11B1LMNAHRH3S1PR1PRKX
SCHEMBL474714 0.89 HSD11B1 (0.43) HSD11B1LMNAHRH3S1PR1PRKX
SCHEMBL474712 0.89 HSD11B1 (0.43) HSD11B1LMNAHRH3S1PR1PRKX
SCHEMBL474713 0.89 HSD11B1 (0.43) HSD11B1LMNAHRH3S1PR1PRKX
SCHEMBL209337 0.88 HSD11B1 (0.48) HSD11B1LMNAHRH3S1PR1PRKX
SCHEMBL2989845 0.88 HSD11B1 (0.48) HSD11B1LMNAHRH3S1PR1PRKX
SCHEMBL209338 0.88 HSD11B1 (0.48) HSD11B1LMNAHRH3S1PR1PRKX
SCHEMBL474724 0.88 HSD11B1 (0.48) HSD11B1LMNAHRH3S1PR1PRKX
SCHEMBL210102 0.88 HSD11B1 (0.48) HSD11B1LMNAHRH3S1PR1PRKX

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2016047-B1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11- BETA-HYDROXYSTEROID DEHYDROGENASE 1 LILLY CO ELI (US) 2013-08-28 EP disclosed
US-8088776-B2 Biphenyl amide lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 ELI LILLY AND COMPANY (US) 2012-01-03 US disclosed
US-20090156571-A1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY 2009-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156571-A1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 HSD11B1, HSD17B1, HSD11B2 HSD11B1 1/4885LMNA 2959/4885HRH3 1964/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.